Overview

Gender

male

Investor Type

Investment Partner

Dr. Felix Olale is an entrepreneur, innovator, physician-scientist and advisor, renowned for his work building businesses and investing in healthcare in emerging markets. Felix has led and advised on transactions of more than $100 million in financing across Africa.

Prior to Leapfrog, Dr. Olale was Executive Chairman of the Excelsior Group, a US and Kenyan-based advisor in emerging markets. While at Excelsior, he co-founded Wellness Group, an East African specialty consultation and medical diagnostics company. Dr. Olale is also a founding member of the Healthcare Advisory Board for Safaricom, the leading Kenyan telecommunications and mobile money operator.

Dr. Olale began his career as a physician-scientist at Skirball Institute of Bio-molecular Medicine in New York, where he cloned two genes involved in organ patterning and regeneration. He also worked as a venture capital analyst at New York University’s Office of Industrial Liaison and Applied Research Fund. Later, he was an Associate Partner and a leader in the Pharmaceutical, Medical Products and Global Health practices at McKinsey & Company in New York.

Dr. Olale holds a Bachelor of Arts, in Molecular Biology, with honors, from the University of Pennsylvania where he was a University Scholar. He received his Medical Degree and Doctorate from NYU School of Medicine. He holds a number of board appointments, including chairing the Governance Committee of PATH, the leading global health innovator, and chairing the Advisory Board of the Institute for Healthcare Management at Strathmore Business School in Nairobi.